Altered lipid metabolism in APC-driven colorectal cancer: the potential for therapeutic intervention DOI Creative Commons
Courtney O. Kelson, Yekaterina Y. Zaytseva

Frontiers in Oncology, Journal Year: 2024, Volume and Issue: 14

Published: March 25, 2024

Altered lipid metabolism is a well-recognized feature of solid cancers, including colorectal cancer. In cancer, upregulation contributes to initiation, progression, and metastasis; thus, aberrant poor patient outcome. The inactivating mutation APC , vital tumor suppressor in the Wnt signaling pathway, key event that occurs early majority cancer cases. potential crosstalk between APC-driven poorly understood. This review collectively highlights summarizes limited understanding mutations Wnt/beta-catenin metabolism. interconnection inactivation activates which causes transcriptome, epigenetic, microbiome changes promote initiation progression. Furthermore, downstream effects this collaborative effort are enhanced stemness, cellular proliferation, prooncogenic signaling, survival. Understanding mechanistic link alterations may foster identification new therapeutic targets enable development more efficacious strategies for prevention and/or treatment

Language: Английский

The Epigenetic Hallmarks of Cancer DOI
Manel Esteller, Mark A. Dawson, Cigall Kadoch

et al.

Cancer Discovery, Journal Year: 2024, Volume and Issue: 14(10), P. 1783 - 1809

Published: Oct. 4, 2024

Abstract Cancer is a complex disease in which several molecular and cellular pathways converge to foster the tumoral phenotype. Notably, latest iteration of cancer hallmarks, “nonmutational epigenetic reprogramming” was newly added. However, epigenetics, much like genetics, broad scientific area that deserves further attention due its multiple roles initiation, progression, adaptive nature. Herein, we present detailed examination hallmarks affected human cancer, elucidating genes involved, dissecting disrupted landscapes for DNA methylation, histone modifications, chromatin architecture define disease. Significance: characterized by constant evolution, spanning from initial premalignant stages advanced invasive disseminated stages. It pathology able adapt survive amidst hostile microenvironments diverse treatments implemented medical professionals. The more fixed setup genetic structure cannot fully provide transformed cells with tools but rapid plastic nature changes ready task. This review summarizes ecological success our bodies.

Language: Английский

Citations

12

Drug tolerant persister cell plasticity in cancer: A revolutionary strategy for more effective anticancer therapies DOI Creative Commons
Jun He,

Zejing Qiu,

Jingjing Fan

et al.

Signal Transduction and Targeted Therapy, Journal Year: 2024, Volume and Issue: 9(1)

Published: Aug. 14, 2024

Non-genetic mechanisms have recently emerged as important drivers of anticancer drug resistance. Among these, the tolerant persister (DTP) cell phenotype is attracting more and attention giving a predominant non-genetic role in cancer therapy The DTP characterized by quiescent or slow-cell-cycle reversible state subpopulation inert specialization to stimuli, which tolerates exposure some extent through interaction multiple underlying recovering growth proliferation after withdrawal, ultimately leading treatment resistance recurrence. Therefore, targeting cells anticipated provide new opportunities for patients, although our current knowledge these remains limited. In this review, we comprehensive overview formation characteristics cells, investigate potential drugs (including preclinical drugs, novel use old natural products) based on different medicine models, discuss necessity feasibility anti-DTP therapy, related application forms, future issues that will need be addressed advance emerging field towards clinical applications. Nonetheless, understanding functions may enable us develop effective improve outcomes patients.

Language: Английский

Citations

9

Epigenomic heterogeneity as a source of tumour evolution DOI
Marthe Laisné, Mathieu Lupien, Céline Vallot

et al.

Nature reviews. Cancer, Journal Year: 2024, Volume and Issue: unknown

Published: Oct. 16, 2024

Language: Английский

Citations

8

Phenotypic noise and plasticity in cancer evolution DOI Creative Commons
Frederick J.H. Whiting, Jacob Househam, Ann‐Marie Baker

et al.

Trends in Cell Biology, Journal Year: 2023, Volume and Issue: 34(6), P. 451 - 464

Published: Nov. 15, 2023

Non-genetic alterations can produce changes in a cell's phenotype. In cancer, these phenomena influence fitness by conferring access to heritable, beneficial phenotypes. Herein, we argue that current discussions of 'phenotypic plasticity' cancer evolution ignore salient feature the original definition: namely, it occurs response an environmental change. We suggest noise' be used distinguish non-genetic phenotype occur independently from environment. discuss conceptual and methodological techniques identify during evolution. propose distinction will guide efforts define mechanisms change, accelerate translational work manipulate phenotypes through treatment, and, ultimately, improve patient outcomes.

Language: Английский

Citations

13

Polyclonal-to-monoclonal transition in colorectal precancerous evolution DOI

Zhaolian Lu,

Shanlan Mo,

Duo Xie

et al.

Nature, Journal Year: 2024, Volume and Issue: unknown

Published: Oct. 30, 2024

Language: Английский

Citations

5

On the Role of Glycolysis in Early Tumorigenesis—Permissive and Executioner Effects DOI Creative Commons
Fabrizio Marcucci, Cristiano Rumio

Cells, Journal Year: 2023, Volume and Issue: 12(8), P. 1124 - 1124

Published: April 10, 2023

Reprogramming energy production from mitochondrial respiration to glycolysis is now considered a hallmark of cancer. When tumors grow beyond certain size they give rise changes in their microenvironment (e.g., hypoxia, mechanical stress) that are conducive the upregulation glycolysis. Over years, however, it has become clear can also associate with earliest steps tumorigenesis. Thus, many oncoproteins most commonly involved tumor initiation and progression upregulate Moreover, recent considerable evidence been reported suggesting upregulated itself, through its enzymes and/or metabolites, may play causative role tumorigenesis, either by acting itself as an oncogenic stimulus or facilitating appearance mutations. In fact, several induced have shown be early tumorigenesis: glycolysis-induced chromatin remodeling, inhibition premature senescence induction proliferation, effects on DNA repair, O-linked N-acetylglucosamine modification target proteins, antiapoptotic effects, epithelial–mesenchymal transition autophagy, angiogenesis. this article we summarize and, following, propose mechanistic model aimed at explaining how such role.

Language: Английский

Citations

12

Cannabis- and Substance-Related Carcinogenesis in Europe: A Lagged Causal Inferential Panel Regression Study DOI Creative Commons
Albert Stuart Reece, Kellie Bennett, Gary Kenneth Hulse

et al.

Journal of Xenobiotics, Journal Year: 2023, Volume and Issue: 13(3), P. 323 - 385

Published: July 18, 2023

Recent European data facilitate an epidemiological investigation of the controversial cannabis-cancer relationship. Of particular concern were prior findings associating high-dose cannabis use with reproductive problems and potential genetic impacts. Cancer incidence age-standardised to world population was obtained from Information System 2000-2020 many national cancer registries. Drug Monitoring Centre for Drugs Addiction. Alcohol tobacco consumption sourced WHO. Median household income taken World bank. rates in high-cannabis-use countries significantly higher than elsewhere (β-estimate = 0.4165, p 3.54 × 10-115). Eighteen forty-one cancers (42,675 individual rates) associated exposure at bivariate analysis. Twenty-five linked inverse-probability-weighted multivariate models. Temporal lagging panel models intensified these effects. In multivariable models, a more powerful correlate or alcohol. Reproductive toxicity evidenced by involvement testis, ovary, prostate breast because some myeloid lymphoid leukaemias implicated occur childhood, indicating inherited intergenerational genotoxicity. Cannabis is important carcinogen alcohol fulfills qualitative quantitative criteria causality 25/41 cancers. transgenerational effects are prominent. These confirm clinical salience as major multigenerational community carcinogen.

Language: Английский

Citations

11

The lifelong natural history of clonal hematopoiesis and its links to myeloid neoplasia DOI
Margarete A. Fabre, George S. Vassiliou

Blood, Journal Year: 2023, Volume and Issue: 143(7), P. 573 - 581

Published: Nov. 22, 2023

Language: Английский

Citations

11

Cell of origin epigenetic priming determines susceptibility to Tet2 mutation DOI Creative Commons
Giulia Schiroli, Vinay K. Kartha, Fabiana M. Duarte

et al.

Nature Communications, Journal Year: 2024, Volume and Issue: 15(1)

Published: May 21, 2024

Abstract Hematopoietic stem cell (HSC) mutations can result in clonal hematopoiesis (CH) with heterogeneous clinical outcomes. Here, we investigate how the state preceding Tet2 mutation impacts pre-malignant phenotype. Using an inducible system for analysis of myeloid progenitors, find that epigenetic features clones at similar differentiation status are highly and functionally respond differently to mutation. Cell stage also influences response indicating origin’s epigenome modulates clone-specific behaviors CH. Molecular associated higher risk outcomes include Sox4 sensitizes cells inactivation, inducing dedifferentiation, altered metabolism increasing vivo output mutant cells, as confirmed primary GMP HSC models. Our findings validate hypothesis predispose specific dominance, explaining why identical genetic different phenotypes.

Language: Английский

Citations

4

Evolutionary trajectories of immune escape across cancers DOI Creative Commons
Wen-Jie Chen, Toby M. Baker, Zhihui Zhang

et al.

bioRxiv (Cold Spring Harbor Laboratory), Journal Year: 2025, Volume and Issue: unknown

Published: Jan. 18, 2025

Abstract Immune escape is a critical hallmark of cancer progression and underlies resistance to multiple immunotherapies. However, it remains unclear when the genetic events associated with immune occur during development. Here, we integrate functional genomics studies immunomodulatory genes tumor evolution reconstruction approach infer across 38 types from Pan-Cancer Analysis Whole Genomes dataset. Different cancers favor mutations in different pathways. For example, antigen presentation machinery highly mutated colorectal adenocarcinoma, lung squamous cell carcinoma, chromophobe renal protein methylation pathway bladder transitional carcinoma adenocarcinoma. We also observe timing patterns instance, impacting involved cellular amino acid metabolism were more likely happen late pancreatic Mutations glucocorticoid receptor regulatory network tended early, while TNF pathways B-cell non-Hodgkin lymphoma. NOD1/2 signaling DNA binding transcription factor activity breast adenocarcinoma ovarian Together, these results delineate evolutionary trajectories highlight opportunities for improved immunotherapy cancer. Significance Despite its role progression, poorly understood. types. Our have important implications developing biomarkers immunoprevention treatment strategies

Language: Английский

Citations

0